论文部分内容阅读
按就诊次序随机分为治疗组和对照组,每组各45例,均在门诊进行观察治疗,每周来门诊复查1次。全部病例于治疗前及疗程结束后进行血常规、便常规及肝功能检查,疗程结束后7日以内复查内镜。治疗组:男38例,女7例,年龄17～50岁,平均39岁,病程2～14年。对照组:男41例,女4例,年龄18～55岁,平均40岁,病程1～18年。治疗组:金刚烷胺100mg,每晚1次口服,四周为一疗程。对照组:雷尼替丁150mg,每日2次口服(早饭前及晚睡前)四周为一疗程。两组治疗开始时
According to the order of treatment were randomly divided into treatment group and control group, 45 cases in each group, were observed in the clinic for treatment, weekly review 1 times. All cases before treatment and after the end of the course of blood, routine and liver function tests, after the end of treatment within 7 days review endoscopy. Treatment group: 38 males and 7 females, aged 17 to 50 years old, average 39 years old, duration of 2 to 14 years. Control group: 41 males and 4 females, aged 18 to 55 years old, average 40 years old, duration of 1 to 18 years. Treatment group: amantadine 100mg, 1 times per night orally, surrounded by a course of treatment. Control group: ranitidine 150mg, 2 times a day orally (before breakfast and before going to bed at night) for a course of treatment. When the two groups started treatment